Match each patient's presenting laboratory profile with the most likely underlying pathophysiological diagnosis. All patients present with a primary hypokalemic metabolic alkalosis and a normal serum creatinine level.
- Serum 2.4 mEq/L, Serum 35 mEq/L, Urine 8 mEq/L, Blood pressure 102/64 mmHgCovert emesis (Extrarenal chloride loss)
- Serum 2.7 mEq/L, Serum 32 mEq/L, Urine 65 mEq/L, Urine ratio 0.02, Blood pressure 112/72 mmHgGitelman syndrome (Distal convoluted tubule defect)
- Serum 2.6 mEq/L, Serum 33 mEq/L, Urine 72 mEq/L, Urine ratio 0.28, Blood pressure 108/68 mmHgBartter syndrome (Thick ascending limb defect)
- Serum 3.0 mEq/L, Serum 31 mEq/L, Urine 58 mEq/L, Plasma Aldosterone/Renin ratio 45, Blood pressure 168/102 mmHgPrimary hyperaldosteronism (Autonomous mineralocorticoid excess)
Answer
The normotensive patient with low urine chloride matches Covert emesis. The hypertensive patient matches Primary hyperaldosteronism. Between the two normotensive salt-wasters, the patient with hypocalciuria matches Gitelman syndrome, and the patient with hypercalciuria matches Bartter syndrome.
The correct matches require a systematic, multi-step interpretation of the laboratory panels. First, blood pressure divides the etiologies: hypertension suggests mineralocorticoid excess, isolating primary hyperaldosteronism. Next, urine chloride separates volume-contracted states attempting to intensely conserve chloride (covert emesis, mEq/L) from renal salt-wasting states ( mEq/L). Finally, urine calcium effectively differentiates the remaining tubulopathies: Bartter syndrome causes hypercalciuria (like loop diuretics), whereas Gitelman syndrome causes hypocalciuria (like thiazide diuretics).
Step-by-Step Solution
Key Concept
Algorithm for evaluating hypokalemic metabolic alkalosis using blood pressure, urine chloride, and urine calcium.
Estimated Time:2m 30s